Inhibition of poly(ADP-ribose) polymerase activity is insufficient to induce tetraploidy

Nucleic Acids Research

Volumn 29, Issue 3, 2001, Pages 841-849

  Simbulan Rosenthal, Cynthia M ^a   Rosenthal, Dean S ^a   Luo, RuiBai ^a   Li, Jia He ^b   Zhang, Jie ^b   Smulson, Mark E ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GUILFORD PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE DERIVATIVE; ENZYME INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL GROWTH; CELL IMMORTALIZATION; CELL SYNCHRONIZATION; CELL VIABILITY; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXPOSURE; FEMALE; FIBROBLAST; FLOW CYTOMETRY; GENETIC STABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TETRAPLOIDY;

ANIMALIA; MURINAE;

EID: 0035253415     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/29.3.841     Document Type: Article

References (69)

1. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease
2. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and men
3. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia
4. Ischemic brain injury is mediated by the activation of poly(ADP-ribose) polymerase
5. Reduction of cognitive and motor deficits after traumatic brain injury in mice deficient in poly(ADP-ribose) polymerase
6. Genetic disruption of poly(ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury
7. Demonstration that poly(ADP-ribose) accumulation occurs in the postischemic heart and is associated with myocardial necrosis
8. Poly(ADP-ribose) polymerase-deficient mice are protected from streptozocin-induced diabetes
9. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin
10. Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozocin-induced diabetes
11. Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism
12. Resistance to endotoxic shock as a consequence of defective NF-κB activation in poly(ADP-ribose) polymerase-1 deficient mice
13. Prevention of endotoxin-induced lethality, but not of liver apoptosis in poly(ADP-ribose) polymerase-deficient mice
14. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase
15. Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation and mucosal injury in murine colitis
16. Neuroprotective effects of inhibiting poly(ADP-ribose) synthetase on focal cerebral ischemia in rats
17. Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain
18. Neuroprotective effects of poly(ADP-ribose) polymerase inhibitors in transient focal cerebral ischemia of rats
19. Nicotinamide reduces infarction up to two hours after the onset of permanent focal cerebral ischemia in Wistar rats
20. Post ischemia treatment with GPI 6150 diminishes poly(ADP-ribose) accumulation during ischemia-reperfusion injury in rat brain
21. Protective effects of 5-iodo-6-amino-1,2-benzopyrone, an inhibitor of poly(ADP-ribose) synthetase against peroxynitrite-induced glial damage and stroke development
22. Inhibition of the activity of poly(ADP-ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle
23. Inhibitors of poly(ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in anesthetized rats in vivo
24. Pharmacologic inhibition of poly (ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats
25. Nicotinamide treatment in the prevention of insulin-dependent diabetes mellitus
26. Effect of nicotinamide treatment on the residual insulin secretion in type 1 (insulin-dependent) diabetic patients
27. GPI 6150, a PARP inhibitor, exhibits strong anti-inflammatory effect in rat models of arthritis
28. 2 cytotoxicity by inhibiting poly(ADP-ribose) polymerase
29. 3-Aminobenzamide synergistically increases sister-chromatid exchanges in cells exposed to methyl methanesulfonate but not to ultraviolet light
30. Potentiation of carcinogen-induced methotrexate resistance and dihydrofolate reductase gene amplification by inhibitors of poly(adenosinediphosphate-ribose) polymerase
31. Stimulation of intrachromosomal homologous recombination in mammalian cells by an inhibitor of poly(ADP-ribosyl)ation
32. A dominant negative mutant of human PARP affects cell recovery, apoptosis and sister chromatid exchange following DNA damage
33. Trans-dominant inhibition of poly(ADP-ribosyl)ation potentiates carcinogen-induced gene amplification in SV40-transformed Chinese hamster cells
34. Depletion of poly(ADP-ribose) polymerase by antisense RNA expression results in a delay in DNA strand break rejoining
35. Depletion of nuclear poly(ADP-ribose) polymerase by antisense RNA expression: Influences on genomic stability, chromatin organization and carcinogen cytotoxicity
36. PARP is important for genomic stability but dispensable in apoptosis
37. DNA ploidy in nonmelanoma skin cancer
38. Chromosomal aberrations in PARP-/- mice: Genome stabilization in immortalized cells by reintroduction of poly(ADP-ribose) polymerase cDNA
39. Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability
40. Requirement for the expression of poly(ADP-ribose) polymerase during the early stages of differentiation of 3T3-L1 preadipocytes, as studied by antisense RNA induction
41. Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Results obtained by a set of methods for sample-storage, staining and internal standardization
42. Inhibitors and activators of ADP-ribosylation reactions
43. DNA repair defect in PARP-deficient cell lines
44. The expression of poly(ADP-ribose) polymerase during differentiation-linked DNA replication reveals that this enzyme is a component of the multiprotein DNA replication complex
45. Regulation of the expression or recruitment of components of the DNA synthesome by poly(ADP-ribose) polymerase
46. Poly(ADP-ribose) polymerase upregulates E2F-1 promoter activity and DNA pol a expression during early S-phase
47. Poly(ADP-ribose) polymerase nuli mouse cells synthesize ADP-ribose polymers
48. PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase
49. Characterization of sPARP-1. An alternative product of PARP-1 gene with poly(ADP-ribose) polymerase activity independent of DNA strand breaks
50. Intact cell evidence for the early synthesis and subsequent late apopain-mediated suppression of poly(ADP-ribose) during apoptosis
51. Transient poly(ADP-ribosyl)ation of nuclear proteins and role for poly(ADP-ribose) polymerase in the early stages of apoptosis
52. Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication
53. Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcoma cells
54. Chemical induction of mitotic checkpoint override in mammalian cells results in aneuploidy following a transient tetraploid state
55. Misregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase
56. Sequential cytogenetic alterations in hamster oral keratinocytes during DMBA-induced oral carcinogenesis
57. Poly(ADP-ribose) polymerase stimulates DNA polymerase alpha
58. Functional association of poly(ADP-ribose) polymerase with DNA polymerase α-primase complex: A link between DNA strand-break detection and DNA replication
59. Poly(ADP-ribosylation) of a DNA topoisomerase
60. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase
61. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage
62. A p53-dependent mouse spindle checkpoint
63. Abnormal centrosome amplification in the absence of p53
64. Inactivation of p53 and the development of tetraploidy in the elastase-SV40 T antigen transgenic mouse pancreas
65. C-myc overexpression and p53 loss cooperate to promote genomic instability
66. Poly(ADP-ribose) polymerase enhances activator-dependent transcription in vitro
67. Poly(ADP-ribose) polymerase binds with transcription factor 1 to MCAT1 elements to regulate muscle-specific transcription
68. Poly(ADP-ribose) polymerase is a coactivator for AP-2-mediated transcriptional activation
69. Regulation of RNA polymerase II-dependent transcription by poly(ADP-ribosyl)ation of transcription factors